
1. aids res hum retroviruses. 2013 oct;29(10):1365-9. doi: 10.1089/aid.2013.0047.
epub 2013 jul 24.

effects raltegravir 2-long terminal repeat circle junctions hiv type 1
viremic aviremic patients.

bona r(1), baroncelli s, d'ettorre g, andreotti m, ceccarelli g, filati p, leone 
p, blasi m, michelini z, galluzzo cm, mallano a, vullo v, cara a.

author information: 
(1)1 department therapeutic research medicines evaluation, istituto
superiore di sanit√† , rome, italy .

although 2-long terminal repeat (2-ltr) circles fraction total 
viral dna infected cells, sequence analysis 2-ltr circles reveals critical 
information regarding viral dna synthesis nature actively replicating 
virus. observed large proportion 2-ltr circular molecules in
the peripheral blood mononuclear cell (pbmc) dna infected individuals are
mutated circle junction. integrase inhibitor raltegravir (ral) blocks 
the strand transfer step integration hiv-1; consequence of
abortive integration significant increase episomal 2-ltr circles is
observed. moreover, demonstrated patients treated highly
active retroviral therapy (haart) changes 2-ltr concentration affect
junction sequences flanking regions 2-ltr. evaluated whether ral
therapy could differential impact 2-ltr circle junctional sequences
in patients different virological profiles time starting ral
therapy. sequence analysis indicates ral acts differently two
populations.

doi: 10.1089/aid.2013.0047 
pmcid: pmc3785805
pmid: 23802629  [indexed medline]

